Ocera Therapeutics Inc (OCRX)

1.79
0.02 1.13
Prev Close 1.77
Open 1.76
Day Low/High 1.76 / 1.85
52 Wk Low/High 0.52 / 2.95
Volume 969.37K
Avg Volume 602.30K
Exchange
Shares Outstanding 26.51M
Market Cap 47.46M
EPS -1.20
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of Ocera Therapeutics, Inc. To Mallinckrodt Plc Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Concerning Whether The Sale Of Ocera Therapeutics, Inc. To Mallinckrodt Plc Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Ocera Therapeutics, Inc.

Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy

Mallinckrodt To Acquire Ocera Therapeutics And OCR-002, Its Proprietary Therapy In Development For Treatment Of Hepatic Encephalopathy

-- Mallinckrodt to commence cash tender offer to purchase Ocera Therapeutics for $1.52 per share, plus Contingent Value Right --

Ocera Initiates Phase 2a Study With Oral OCR-002 In Patients With Cirrhosis

Results Expected by Year-End 2017

Ocera To Present At The 16th Annual Needham Healthcare Conference

-- Company Presentation Scheduled for April 4, 2017 at 4:20 PM ET --

Ocera To Present At The Cowen And Company 37th Annual Healthcare Conference

Company Presentation Scheduled for March 8, 2017 at 11:20 AM ET

Ocera To Present At The Stifel 2016 Healthcare Conference

Ocera To Present At The Stifel 2016 Healthcare Conference

Company Presentation Scheduled for November 16, 2016 at 11:45 AM ET

Ocera Therapeutics Announces Late-Breaker Abstract Accepted For Presentation At The AASLD Liver Meeting 2016

Ocera Therapeutics Announces Late-Breaker Abstract Accepted For Presentation At The AASLD Liver Meeting 2016

-- Encouraging Data from NIH-Sponsored Study of OCR-002 in the Treatment of Patients with Acute Liver Failure --

Ocera To Present At The 2016 BIO Investor Forum

Ocera To Present At The 2016 BIO Investor Forum

Company Presentation Scheduled for October 18, 2016 at 8:30 AM PT

Ocera To Present At The Ladenburg Thalmann 2nd Annual Healthcare Conference

Ocera To Present At The Ladenburg Thalmann 2nd Annual Healthcare Conference

Company Presentation Scheduled for September 27, 2016 at 12:00 PM ET